• 1. Evidence of rutile-to-anatase photo-induced electron transfer in mixed-phase TiO2 by solid-state NMR spectroscopy?
  Weili Dai,Guangjun Wu,Michael Hunger Chem. Commun., 2015,51, 13779-13782
• 2. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
• 3. Embedding heteroatoms: an effective approach to create porphyrin-based functional materials
  Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341
• 4. Embedding cyclic nitrone in mesoporous silica particles for EPR spin trapping of superoxide and other radicals?
  Eric Besson,Stéphane Gastaldi,Emily Bloch,Selma Aslan,Hakim Karoui,Olivier Ouari,Micael Hardy Analyst, 2019,144, 4194-4203
• 5. Evolutionary approaches in protein engineering towards biomaterial construction
  Brindha J.,Balamurali M. M.,Kaushik Chanda RSC Adv., 2019,9, 34720-34734

Professional Introduction to 4-Amino-[1,1'-biphenyl]-3-carbonitrile (CAS No. 55675-86-0)

4-Amino-[1,1'-biphenyl]-3-carbonitrile, with the CAS number 55675-86-0, is a specialized organic compound that has garnered significant attention in the field of chemical and pharmaceutical research. This compound, featuring a biphenyl core with an amino group at the 4-position and a nitrile group at the 3-position, exhibits unique structural and chemical properties that make it a valuable intermediate in the synthesis of various pharmacologically active molecules.

The biphenyl scaffold is a common motif in medicinal chemistry due to its ability to confer rigidity and specific spatial orientation to drug molecules, enhancing their binding affinity to biological targets. The presence of both an amino group and a nitrile group on the biphenyl ring introduces additional functionalization possibilities, allowing for further derivatization into more complex structures. These features make 4-Amino-[1,1'-biphenyl]-3-carbonitrile a versatile building block for the development of novel therapeutic agents.

In recent years, there has been growing interest in the use of biphenyl derivatives in the treatment of various diseases, including cancer, inflammation, and neurological disorders. The amino and nitrile groups provide handles for chemical modification, enabling the design of molecules with tailored biological activities. For instance, studies have shown that biphenyl-based compounds can interact with specific enzymes and receptors involved in disease pathways, making them promising candidates for drug development.

One of the most exciting areas of research involving 4-Amino-[1,1'-biphenyl]-3-carbonitrile is its potential application in oncology. Researchers have been exploring its derivatives as inhibitors of kinases and other enzymes that play critical roles in cancer cell proliferation and survival. The rigid biphenyl core helps stabilize the binding of these compounds to their targets, while the amino and nitrile groups allow for further optimization to improve potency and selectivity. Preliminary studies have demonstrated promising results in vitro and in animal models, suggesting that this compound could be a valuable asset in the fight against cancer.

Another area where this compound has shown promise is in the treatment of inflammatory diseases. Inflammation is a hallmark of many chronic conditions, including rheumatoid arthritis and inflammatory bowel disease. By targeting key inflammatory pathways, biphenyl derivatives like 4-Amino-[1,1'-biphenyl]-3-carbonitrile could offer new therapeutic strategies. The ability to modify the structure of this compound allows researchers to fine-tune its biological activity, making it an attractive scaffold for developing anti-inflammatory agents.

The synthesis of 4-Amino-[1,1'-biphenyl]-3-carbonitrile involves multi-step organic reactions that require careful optimization to ensure high yield and purity. Common synthetic routes include nucleophilic substitution reactions on halogenated biphenyl precursors followed by functional group transformations to introduce the amino and nitrile groups. Advances in synthetic methodologies have made it possible to produce this compound more efficiently, enabling larger-scale applications in research and drug development.

The chemical properties of 4-Amino-[1,1'-biphenyl]-3-carbonitrile, such as its solubility and stability, also play a crucial role in its utility as a pharmaceutical intermediate. These properties must be carefully considered during both synthesis and formulation to ensure that the compound behaves as expected in various applications. For example, solubility issues can be addressed by incorporating solubilizing agents or by using prodrugs that release the active compound under specific physiological conditions.

In conclusion, 4-Amino-[1,1'-biphenyl]-3-carbonitrile (CAS No. 55675-86-0) is a highly versatile intermediate with significant potential in pharmaceutical research. Its unique structural features make it an excellent candidate for synthesizing novel therapeutic agents targeting various diseases. As research continues to uncover new applications for this compound, it is likely to remain a cornerstone of drug development efforts in the coming years.

• 95-68-1(2,4-dimethylaniline)
• 88-05-1(2,4,6-Trimethylaniline (Mesidine), ND25=1,4959)
• 91-95-2(3,3′-Diaminobenzidine)
• 84-67-3(2,2'-Dimethyl-1,1'-biphenyl-4,4'-diamine)
• 87-59-2(2,3-Dimethylaniline)
• 87-62-7(2,6-Dimethylaniline)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)